NW

Nina Webster

Dimerix Limited | Chief Executive Officer, Managing Director
Ms Webster has experience in the pharmaceutical industry, with leadership roles across strategy, commercialization, intellectual property, scientific and operational aspects of product development. Nina worked in large Pharma, Wyeth Pharmaceuticals (UK). Nina is also a Non-Executive Director of Linear Clinical Research Limited and SYNthesis BioVentures Pty Ltd.

Company and Roles

Company
Title
Tenure
Since
DXB
DXB
Dimerix Limited
  • Chief Executive Officer
  • Managing Director
6yrs, 3mthAug 2018

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
DXB
DXB
Dimerix Limited
21/10/240409,2503,680,873N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
DXB
DXB
Dimerix Limited
21/10/24
Issued
1,500,000$0.367$550,740Employee Share Ownership Plan
DXB
DXB
Dimerix Limited
10/04/24
Expiry
25,000$0.305$7,625Options expired
DXB
DXB
Dimerix Limited
27/03/24
Buy
33,000$0.310$10,230On-market trade
DXB
DXB
Dimerix Limited
19/03/24
Issued
93,750$0.126$11,812Exercise of options
DXB
DXB
Dimerix Limited
19/03/24
Exercise
93,750$0.126$11,812Exercise of options